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The development of in vitro hematopoietic assay systems has permitted the
identification ofspecificcell subpopulations that aresusceptible to transformation
induced by retroviruses containing different oncogenes. In particular, studies
using a colony-forming assay that is dependent upon the presence of 2-ME have
revealed that pre-B cells were transformed when cultures were infected with
viruses containing abl or fes, oncogenes that code for tyrosine-specific protein
kinases (1, 2). By comparison, cultures infected with viruses containing bas, H-
ras, or K-ras, oncogenes that code for proteins with guanidine diphosphate
(GDP)'-binding activity (3), produced transformed hematopoietic cell lines that
lacked characteristics ofcells in the B, T, or erythroid cell lineages (4). Although
one continuous line was shown to have myeloid characteristics (5), most of the
cell lines transformed by ras-containing retroviruses expressed high levels of
terminal deoxynucleotidyl transferase (TdT) activity, suggesting that they were
derived from cells at an early stage within the lymphoid differentiation pathway.
Transformed lines with characteristics similar to those of the ras-induced neo-
plasms were also obtained from hematopoieticcell cultures infected with a murine
recombinant retrovirus containing the src oncogene that, like abl andfes, codes
for a tyrosine-specific kinase (6).
To more clearly define the characteristics of the cell populations transformed
by the bas, H-ras, K-ras, and src oncogenes, continuousclonal cell lines produced
from infected bone marrow andfetal liver cultures were examined for expression
of lineage-specific cell-surface antigens, expression of cytoplasmic t chain (cm),
and the organization of Ig heavy and light chain genes. The results show that
cell lines with characteristics of pro-B and pre-B cells were obtained from cells
infected with viruses containing bas, H-ras, K-ras, and src, as well as abl andfes.
In addition, two cell lines transformed by ras-containing viruses were found to
'Abbreviations used in this paper:
￿
ABL, Abelson MuLV; BMSV, Balb murine sarcoma virus; cp,
cytoplasmic A chain; FeSV, Snyder Theilen feline sarcoma virus; FMF, flow microfluorometry; FU,
fluorescence units; GDP, guanidine diphosphate; HMSV, Harvey murine sarcoma virus; KMSV,
Kirsten sarcoma virus; MRSV, murine Rous sarcoma virus; MuLV, murine leukemia virus; NSE,
nonspecific esterase; s1g, surface immunoglobulin; TdT, terminal deoxynucleotidyl transferase.
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TABLE I
Antibodies Used in This Study
* Purchased from New England Nuclear (Boston, MA).
Purchased from Becton Dickinson and Co. (Mountain View, CA).
§ PEM, Peritoneal exudate macrophage.
coexpress antigens usually restricted to the B cell or myeloid pathways of
differentiation. Detailed analyses of these two lines suggest that the initial
transforming event giving rise to these lines occurred in a precursor common to
the B cell and myeloid lineages.
Materials and Methods
Cell Lines.
￿
The cell lines examined were obtained from cultures of fetal liver cells or
bone marrow cells from 2-3-wk-old NFS/N mice that were infected as described (4) with
amphotropic murine leukemia virus (MuLV) or Moloney MuLV pseudotypes of replica-
tion-defective retroviruses containing the Rous sarcoma virus (MRSV) src oncogene (6),
the Harvey sarcoma virus (HMSV) H-ras oncogene (4), the BALB sarcoma virus (BMSV)
bas oncogene (4), the Kirsten sarcoma virus (KMSV) K-ras oncogene, the Snyder-Theilen
feline sarcoma virus (FeSV)fes oncogene (2), or the Abelson murine leukemia virus (ABL)
abl oncogene. Individual colonies appearing in the soft agar cultures were harvested,
cultured in suspension in microtiter wells, and grown to bulk cultures, usually with the
use of adherent feeder layers. Cell lines expanded in the presence of feeder layers were
recloned in soft agar before further characterization . All the cell lines were shown to
contain and express the oncogenes used in their induction (2, 4-6).
Flow Microfuorometry (FMF).
￿
FMF analyses were performed on a FAGS II (Becton
Dickinson and Co., Sunnyvale, CA) using established techniques (7) in which viable cells
were electronically gated by narrow forward-angle light scatter and uptake of propidium
iodide (8). Cells were reacted with the panel of monoclonal and alloantibodies shown in
Table I and with FITC-labeled goat anti-mouse K antibodies (Southern Biotechnology
Assoc., Birmingham, AL.) to detect surface Ig (sIg). Binding of antibodies to Lyb-8.2, la,
and Ly-17 .1 was detected using a FITC-labeled goat anti-mouse IgG (Southern Biotech-
nology Assoc.). Binding of antibodies to Mac-2 and Mac-3 was detected using a FITC-
labeled rabbit anti-rat IgG (Zymed Laboratories, San Francisco, CA). All other reagents
used were directly labeled with FITC.
Two-color FMF was performed using FITC-labeled anti-Mac-1 and biotin-labeled anti-
Lyb-2 .1 or anti-Ly-5(B220) (prepared in our laboratory) and Texas Red-labeled avidin
(Cappel Laboratories, Malvern, PA). To prevent binding of antibodies via their Fc
Antigen Clone Nominal specificity Reference
Thy-1 .2 NEI-005* T cells 9
Ly-1 NEI-017* T cells, B cell subpopulation 9
Ly-2 53-6.7$ Some T cells 9
Lyb-2 .1 10 .1-D2 Pre-B, B cells 10
Ly-5 30-Fl I Pan leukocyte 9
Ly-5 (B220) RA3-6B2 Pre-B, B cells 1 I
Lyb-8.2 CY-34-1.1 Pre-B, B cells 12
Ly-17 2AG2 Pre-B, B cells, myeloid cells 13, 14
Ly-17 .1 Alloantisera Pre-B, B cells myeloid cells 14, 15
la` 10.3-6 B cells, macrophages 16
ThB 53-9.2 Pre-B, B cells, thymocytes 9
MAC-1 M1/70 Monocytes, macrophages 17
MAC-2 M3/38 Thioglycollate-elicited PEM§ 18
MAC-3 M3/84 PEM, Thioglycollate-elicited PEM 19
°6C3" 6C3 B Lineage neoplasms 20HOLMES ET AL.
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portions, 106 cells were incubated with 10 tig of unlabeled anti-Fc .y receptor (clone
2AG2, reference 13) before incubation with labeled antibodies.
Cell Sorting.
￿
Cells from the HMSV-infected line, HAFTL3, and the BMSV-infected
line, BAMC1, were sorted into Mac-1 + (Mac-l'-sorted) or Mac-1- (Mac-1 --sorted) popu-
lations using the FACS II cell sorter and/or were single cell-cloned by sorting Mac-I +
(Mac-l+-cloned) or Mac-1 - (Mac-1--cloned) cells into individual wells of 96-well round
bottomed microtiter plates using an Epics V (Coulter Electronics, Hialeah, FL) flow
cytometry system.
Measurement ofIg A and K Chains.
￿
The amount of mouse Ig to and K chains present in
cells was determined by competition RIA, as described previously (2).
Molecular Assays.
￿
High molecular weight DNA was prepared, digested with restriction
enzymes, separated on 0.8% agarose gels, and transferred to nitrocellulose using estab-
lished techniques. Southern blots were hybridized with 12P-labeled DNA probes at 65°C
in a buffer containing 3x SSC, 10% dextran sulphate, IOx Denhardt's solution, 0.1%
SDS, 5 mM EDTA, and 50 Ag/ml salmon sperm DNA. Blots were washed successively in
3x SSC at 37°C for 20 min, lx SSC at 65°C for 10 min and 0.2x SSC at 65°C for 30
min, and analyzed by autoradiography. Two probes were used, j., a 1 .96-kb Bam HI/Eco
RI fragment of the BALB/c germline J region (21) and JK, a 2.8-kb Hind III/Hind III
fragment of pEC, (22).
Assays for Macrophage Function.
￿
The assay for nonspecific phagocytosis was carried
out in chamber slides (4008 ; Miles Laboratories Inc., Naperville, IL). Cells were inoculated
with 100 MI of 1-,m latex beads (15711 ; Polysciences, Inc ., Warrington, PA) and incubated
at 37°C for 3 h. Slides were washed in PBS, stained with Wright's-Giemsa and cells were
scored for bead ingestion at x 100 magnification. Lysozyme was assayed by the lysoplate
assay using egg white lysozyme as a standard (5). Levels of lysozyme were expressed in /Ag
per 106 cells per 24 h. The presence of nonspecific esterase was determined by cytochem-
ical staining using a Sigma Chemical Co. (St. Louis, MO) research kit (5).
Results
Phenotypic Analyses.
￿
Cell lines were analyzed by FMF for expression of cell
surface antigens characteristic of cells in the B, T, and myeloid lineages (Table
I) . The results showed that all of the transformed cell lines, irrespective of the
oncogene-containing retrovirus used in their induction, had characteristics of
early cells in the B lymphocyte lineage (Table II). The phenotypes exhibited by
the different lines correspond to several stages of maturation in a recently
proposed scheme of B cell development (23, 24; Fig. 1). In this scheme, it was
postulated that Ly-17 + ,Lyb-2+ cells, provisionally termed pro-B cells, are the
progenitors of Ly-5(B220)+ large pre-B cells defined in other studies (11) . Large
pre-B cells differentiate into ThB+ small pre-B cells, which become mature B
cells with the acquisition of sIg (11). Expression of la antigens by B cells occurs
either simultaneously with or subsequent to sIg expression (25, 26) .
In the present study, two cell lines (BASC6 and HRC3) were Ly-17+, Lyb-2+,
but Ly-5(B220)-, ThB- , la-, and sIg, a phenotype that corresponds to the pro-
B cell stage of differentiation (Table II and Fig. 1). 14 of the lines were Lyb-2+
and uniformly Ly-5(B220)+ , or contained subpopulations of Ly-5(B220)+ cells
and were ThB-, sIg, and la-, and therefore corresponded to the large pre-B
cell stage of differentiation. Two lines YIC1 and HAFTL3, contained subpop-
ulations of ThB+ cells and Ia+ cells. Finally, two lines (HAFTLI and FE2NCI)
were Ly-17+, Lyb-2+, Ly-5(B220)+, and Ia+l-, sIg, and ThB- a phenotype with
no documented counterpart in studies of normal or malignant cells within the B
lymphocyte lineage (25, 26). This finding raises the possibility that la may
sometimes be expressed before ThB or sIg during normal B cell maturation.446
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FIGURE 1 .
￿
Scheme of B cell differentiation showing established (solid arrows) and proposed
pathways (broken arrows).
The majority of the lines (16/20), including both of the pro-B cell lines, were
Ly-1 +, a finding consistent with previous reports that expression of Ly-1 occurs
very early during the development of the Ly-1' B cell lineage (27-30). In
addition, all the cell lines but two expressed the antigen recognized by the inAb
6C3, recently shown to be expressed at low levels on some normal bone marrow
cells (31) and at high levels in many MuLV-induced B and pre-B cell lymphomas
(reference 20 and unpublished observations). The pattern of expression of Lyb-
8.2 and Ly-5(B220) on these lines suggests that these antigens may be expressed
simultaneously during B cell differentiation (see Fig. 1). The observation that all
of the lines expressed Ly-17.1, recently shown to be a polymorphic determinant
of the Fc y receptor (14), is consistent with previous suggestions that this antigen
may be expressed very early in B cell differentiation (23). It is noteworthy that
two cell lines, FEMCL andJP4-1, expressed Thy-1, a cell surface antigen usually
associated with the T cell lineage among murine hematopoietic cells, but that
may also be expressed during myeloid differentiation (32, 33).
Two cell lines, HAFTL3 and BAMC1, were of particular interest. Cells from
these lines were uniformly Lyb-2+, Ly-5(B220)+, and ThB-, corresponding to
the large pre-B cell stage of differentiation, yet both lines were Mac-I-/', i.e.,
contained subpopulations (10-15%) of Mac-1+ cells (see Table II legend). Expres-
sion of Lyb-2 and Ly-5(B220) by BAMC1 was surprising, since this line was
previously shown to be Mac-1+ and to express other characteristics consistent
with immature cells of the myeloid lineage (5).
Ig Gene Organization and Expression.
￿
High molecular weight DNA extracted
from the cell lines was digested with Eco RI or Hind III and hybridized with the
JH or thejK probes, respectively. Resultsof hybridization with theJH probeshowed
that all of the lines had undergone rearrangements of this locus on at least one
of the two chromosomes bearing JH genes (Table II and Fig. 2) . Hybridization
with the JK probe showed that only three cell lines exhibited rearrangements of
rc light chain genes (Table II and Fig. 3). The results obtained with both probes
yielded no evidence that any of the lines, in particular in HAFTL3 and BAMC1,
were not monoclonal. Productive Ig gene rearrangements resulting in production
of citt molecules were observed only in three cell lines: AAC6, FE2NCI, and
FEUC (Table 11). No K chain protein was detected in any of the lines, including
those that had rearrangements at the K gene locus.
Analysis ofMac-]' and Mac-]- Subpopulations ofHAFTL3 andBAMCI Obtained448
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FIGURE 2 .
￿
Southern blot of Eco RI-digested DNA from : NFS spleen (1), NFS liver (2),
HAFTLI (3), BAMCI (4), JP2 (5), AAC6 (6), HAFTL2 (7), YICI (8), JP7 (9), HSIC5 (10),
HRC3 (11), FEUC (12), FE2NCI (13), and KFFTLI (14) hybridized with the JH probe .
by Cell Sorting.
￿
The observations that HAFTL3 and BAMCI were uniformly
positive for expression of the B lineage antigens Lyb-2 and Ly-5(B220) but Mac-
1 -I+ (Table II) indicated that subpopulations of both cell lines simultaneously
expressed both myeloid and B lineage cell-surface antigens . This was confirmed
by two-color FMF analyses ofHAFTL3 and BAMCI for expression ofMac-1 in
relation to Lyb-2 .1 or Ly-5(B220) (data not shown) . To determine whether the
subpopulations of Lyb-2+, Ly-5(B220)+, Mac-I-, and Lyb-2+, Ly-5(B220)', Mac-
I' cells in HAFTL3 and BAMCI could be propagated as phenotypically stable
cell lines, HAFTL3 andBAMCI were sorted by FMF into nonoverlapping Mac-
I' and Mac-1- populations . After expansion in liquid culture, both the Mac-I+-
sorted and Mac-l--sorted HAFTL3 lines were Mac- I-I' when analyzed by FMF.
To determine whether the observed heterogeneity was due to contamination
between sorted populations, HAFTL3 Mac-l+ and Mac-1- populations were
single cell-cloned by FMF. Analysis of clones for the expression of Mac-1 using
fluorescence microscopy revealed that at I wk after sorting (^-500 cells per well),
Mac-1--cloned cells were uniformly Mac-I-, whereas at 2 wk, 5 out of 5 clones
analyzed were Mac-1 -1' . FMF analysis of Mac-1 --cloned lines after expansion in
culture showed that 29 of 31 clones were Mac-1 -1+ and 2 were uniformly Mac-
1+ . In contrast, Mac-l+-cloned HAFTL3 cells were uniformly Mac-I' when
analyzed by fluorescence microscopy at 1 and 2 wk after sorting . 12 of 13 lines,
expanded in culture and analyzed by FMF, were uniformly Mac-1+ and one was
Mac-l'I- . These results showed that Mac-I' HAFTL3 cells were derived from
Mac-I - cells . Moreover, hybridization of the J,, probe with DNA prepared fromHOLMES ET AL .
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FIGURE 3 .
￿
Southern blot of Hind III-digested DNA from : NFS liver (1), JP5 (2), BASC6C2
(3),JP2 (4), and FEUC (5), hybridized with theJ, probe .
the parental HAFTL3 line and the uniformly Mac-1 + subclone HAFTL3-A,
showed that both lines had identicalJ rearrangements (Fig . 4) .
Two HAFTL3 Mac-1+ subclones, HAFTL3-A and -3D10, were analyzed
further for expression of Lyb-2, Ly-5(B220), and Ia ; for the macrophage-lineage
antigens Mac-2 and Mac-3; for production of lysozyme and nonspecific esterase
(NSE) ; and fortheir ability to phagocytose latexbeads (Table 111) . Both subclones
were uniformly la', Lyb-2+, and Ly-5(8220)+; produced high levels of lysozyme
and NSE; and were phagocytic . HAFTL3-A, in comparison with HAFTL3-
3D10, produced higher levels of both enzymes, was more actively phagocytic,
and also expressed Mac-2, an antigen normally found on thioglycollate-elicited
peritoneal macrophages (18) . Both lines were Mac-3- . Consistent with these
phenotypic and functional characteristics, HAFTL3-A had morphological fea-
tures typical ofamature macrophage (Fig . 5 b) . In contrast, theparental HAFTL3
cells had a distinctive lymphoid morphology (Fig . 5a) .
BAMC I was originally described as a myeloid-lineage cell line (5), butattempts
to obtain stable uniformly Mac-I+ cell lines from BAMC1 by single cell-cloning
were unsuccessful . FMF analysis of 24 subclones generated from both Mac-1--450
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FIGURE 4 .
￿
Southern blot of Eco RI-digested DNA from : C3H liver (1), HAFTL3-A (2), and
HAFTL3 (3), probed with the JH probe .
clonedand Mac-l+-clonedBAMC 1 showed that they were either Mac-1- or Mac-
1 +1-. However, one Mac-l+-cloned line, BAMC1-4E10, which was Mac-1',- , had
twofold higher levels of lysozyme production than the parental BAMC 1 line,
and could be induced to produce higher levels of lysozyme and become >80%
Mac-1+ after stimulation with the phorbol ester, PMA (data not shown) .
Discussion
The results of this study show that in vitro infection of bone marrow or fetal
liver cells with retroviruses containing the bas, H-ras, K-ras, src, abl, and fes
oncogenes induces the transformation of early B lineage cells . Analyses of these
cell lines for expression of cell-surface antigens and Ig gene organization showed
that they had remarkably similar phenotypes, regardless of whether the virusesHOLMES ET AL.
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TABLE III
Characterization ofMac-1+ Sublines of HAFTL3
* Determined by FMF.
T,ug/106cells/24 h.
§ Relative amounts of reaction productas compared with a negative control.
Average number of latex beads in cytoplasm of positive cells according to the following scheme:
+++, >75 beadsper cell; +, between 5 and 25 beads per cell. Numbersin parentheses indicate the
percentages of cells with >5 beads per cell.
used for infection contained oncogenes coding for tyrosine-specific kinases or
GDP-binding proteins (Table II). These data confirm reports of transformation
ofpre-B cellsby abl andfes (1, 2, 34) and significantly extend previous phenotypic
characterization of ras- and src-induced hematopoietic cell transformants (4-6).
It was previously shown that infection of bone marrow or fetal liver cells with
ras- or src-containing retroviruses induced the transformation of cells that were
assumed to be lymphoid progenitor cells because they were sIg, ctt, but
expressed high levels of TdT (4, 6). Ras-containing viruses also induced altera-
tions in the growth and differentiation of myeloid cells, although only one
continuous cell line, BAMC 1, was isolated from these cultures (5). In the present
study, extensive analyses of the ras- and src-transformants have shown that all
had phenotypes characteristic of pre-B cells and that most corresponded to the
large pre-B cell stage of differentiation, i.e ., were Lyb-2+, Ly-5(B220)+, ThB-,
and sIg. However, two cell lines, HAFTL3 and BAMC 1, contained subpopu-
lations of Lyb-2+, Ly-5(B220)+, Mac-1+ cells that differentiated or could be
induced to differentiate into cells with mature macrophage characteristics after
single-cell FMF cloning.
These results raise the question as to the nature of the initial cell transformed
by these oncogene-containing viruses. The target cell may be a totipotent stem
cell that, under the culture conditions employed, preferentially differentiates
within the B cell lineage. Although most leukemia-derived cell lines show a
restricted pattern of differentiation, a transformed cell line with the capacity to
differentiate within the T, myeloid, and erythroid lineages has been established
from a patient undergoing treatment with deoxycoformycin, an adenosine de-
aminase inhibitor (35). An alternative hypothesis is that a cell with a more
restricted differentiation potential may be targeted in this system. In this regard,
the characteristics of most of the cell lines examined are consistent with the
transformation of an early B cell progenitor giving rise to these lines.
In the clinical literature, there are numerous examples of leukemias and
lymphomas that, similar to HAFTL3 and BAMC1, coexpress markers usually
restricted to distinct hematopoietic cell lineages. These observations have led to
two divergent interpretations. McCulloch has argued that cells with these char-
acteristics are decidedly abnormal and that genetic misprogramming during the
production of leukemic cells results in the coexpression of markers usually
Line
la
Cell surface
Mac-1
antigen*
Mac-2 Mac-3 Lysozymet
Function
NSE§ Phagocytosisl
HAFTL3 -/+ -/+ - - <0.1 - ND
HAFTL3-A + + + - 12.5 ++ +++(97%)
HAFTL3-3D10 + + - - 5.0 + +(5%)452
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restricted to distinct hematopoietic cell lineages. He has coined the term "lineage
infidelity" to describe this process (36). In contrast, Greaves et al . (37) suggest
that these leukemic phenotypes reflect the persistent expression by progeny
leukemic blasts of genes usually expressed only transiently by their bipotential
or multipotential progenitors. They refer to this pattern of phenotypic expression
in normal differentiation and leukemia as lineage promiscuity. Till (38) hasraised
similar arguments with respect to normal hematopoiesis.
Earlier studies of a large number of murine leukemias and lymphomas led us
to propose models of normal hematopoietic differentiation (39) and more partic-
ularly of B cell differentiation (Fig. 1 and References 23, 24, 40). These models
were based, in part, on the assumption that neoplasms with characteristics not
represented among known normal cell phenotypes may provide important clues
to lineage relationships . This view is similar to that supported by Greaves and
coworkers (37), and leads to the suggestion that the results presented here and
elsewhere support the hypothesis of a close developmental relationship between
the B cell and myeloid lineages.
HAFTL3 and BAMC 1 have characteristics thoughtto represent committment
to the B cell lineage, including the expression of Lyb-2 and Ly-5(B220) and the
rearrangement of Ig heavy chain genes. However, these lines have retained the
capacity to differentiate within the macrophage lineage. Although this may not
reflect a normal differentiation pathway, it may indicate that the transformation
event occurred in a common B cell/myeloid progenitor cell. We have previously
suggested that this cell type be termed a pro-GMB cell, to indicate its potential
for producing cells in the granulocyte, macrophage, and B cell lineages, and
predicted that it would have a Ly-17+, Mac-l+ phenotype (Fig. 1 and reference
23). Cells coexpressing Lyb-2 and Mac-1, and therefore corresponding to the
putative pro-B cell (Fig. 1) make up a large percentage of spleen and bone
marrow cells of newborn mice (24). In addition, neonatal liver cells expressing
Ly-5(B220) and possessing peroxidase positive granules have been described
(41). Studies are in progress to determine the potential of these cells to differ-
entiate within the B or myeloid lineages.
Coexpression of B lineage and myeloid antigens, similar to that seen in
HAFTL3 and BAMC1, has been reported for other cell lines that were induced
with murine leukemia viruses or with chemical carcinogens (23, 24, 40, 42).
Among these is an Abelson MuLV-induced pre-B cell line, ABLS 8.1, which was
induced to become a macrophage line with the addition of the demethylating
agent, 5-azacytidine (42) . Similar reports were obtained when the phorbol ester,
PMA, was added to a B lineage cell line established from a patient having a
t(4;1 1) translocation (43). In both of these cases, the original tumor cell line had
rearranged Ig genes. The differentiation potential of HAFTL3 was realized
without the addition of inducing agents, whereas earlier passages of BAMC1 (5)
and the Mac-l+-cloned line, BAMC1-4E10, showed increased expression of Mac-
1 and lysozyme in response to PMA stimulation.
Studies of human leukemias also provide support forthe existenceof a common
B/myeloid progenitor cell. The most well documented is the occurrence, in 30%
of patients, of a lymphoid blast crisis (ofpre-B cell phenotype) in the acute phase
of chronic myelogenous leukemia (44, 45). The Philadelphia chromosome t(9;22)454
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translocation (46, 47) and G6PD isoenzymes (47) have been used as markers for
clonality of cells involved in the lymphoid blast crisis and in the chronic phase of
myelogenous leukemia . In addition, there have been reports of patients with
acute leukemia in which the leukemia was either composed of a mixture of both
myeloid and lymphoid cells (48), or there was a conversion from acute lympho-
blastic leukemia to acute myeloid leukemia (48), or the leukemia was composed
of cells that coexpressed both B lineage and myeloid markers (49, 50). Other
examples of the coexpression of B- and myeloid-associated antigens by human
leukemic cells have recently been reviewed (37) .
If our interpretation of these data is correct, it would be expected that cell
lines that display clear, albeit early, markers of committment to either the B cell
or myeloid pathways of differentiation might also exhibit potential to mature
within either lineage. Evidence for this comes from recent studies of single-cell
cloned progeny of HAFTLI (Table II). Stimulation of some clones with LPS
results in induction of multiple JH rearrangements and the sequential expression
of ThB and la, events associated with maturation within the B cell lineage (Fig.
1) . By comparison, other clones develop characteristics of mature macrophages
(Davidson, W. F., J. H. Pierce, S. Rudikoff, and H. C. Morse, III; manuscript in
preparation).
In conclusion, these studies indicate that an unexpectedly wide range of one
genes can induce B lineage lymphomas in vitro. The availability of cell lines with
both myeloid and B cell differentiation potentials provides a unique opportunity
to explore the molecular and biochemical events that define irrevocable com-
mittment to these distinct hematopoietic lineages.
Summary
In vitro infection of bone marrow or fetal liver cells with retroviruses contain-
ingfes, abl, ras, or src oncogenesresulted in the transformation of early B lineage
cells. All cell lines tested possessed rearrangements at the Ig heavy chain locus
and some had rearrangements at the K chain locus. The majority of the lines
corresponded phenotypically to Lyb-2+, Ly-5(B220)', ThB- large pre-B cells,
although some were classified as pro-B cells because of their Lyb-2+, Ly-17+, Ly-
5(B220)- phenotype. We identified two cell lines that contained subpopulations
of cells that coexpressed the B lineage antigens Lyb-2 and Ly-5(B220) and the
myeloid lineage antigen Mac-1 . Single-cell FMF cloning of these subpopulations
showed that Mac-1 + cells were derived from Mac-1 - cells and that these Mac-1 +-
cloned cells further differentiated into cells with phenotypic and functional
characteristics of mature macrophages .
We wish to acknowledge the expert technical assistance of Mr. Chuck Knicely.
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